<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9604935</journal-id>
<journal-id journal-id-type="pubmed-jr-id">22377</journal-id>
<journal-id journal-id-type="nlm-ta">Addict Biol</journal-id>
<journal-id journal-id-type="iso-abbrev">Addict Biol</journal-id>
<journal-title-group>
<journal-title>Addiction biology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1355-6215</issn>
<issn pub-type="epub">1369-1600</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29316088</article-id>
<article-id pub-id-type="pmc">6037617</article-id>
<article-id pub-id-type="doi">10.1111/adb.12591</article-id>
<article-id pub-id-type="manuscript">NIHMS925102</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Beyond Genome-wide Significance: Integrative Approaches to the Interpretation and Extension of GWAS Findings for Alcohol Use Disorder</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Salvatore</surname>
<given-names>Jessica E.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Han</surname>
<given-names>Shizhong</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Farris</surname>
<given-names>Sean P.</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mignogna</surname>
<given-names>Kristin M.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Miles</surname>
<given-names>Michael F.</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Agrawal</surname>
<given-names>Arpana</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Psychology, Virginia Commonwealth University, Box 842018, Richmond, VA 23284-2018, United States</aff>
<aff id="A2">
<label>2</label>Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Box 980126, Richmond, VA 23298, United States</aff>
<aff id="A3">
<label>3</label>Department of Psychiatry, University of Iowa, 22G General Hospital, Iowa City, Iowa 52242, United States</aff>
<aff id="A4">
<label>4</label>Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland, 21287, United States</aff>
<aff id="A5">
<label>5</label>Waggoner Center for Alcohol and Addiction Research, The University of Texas at Austin, Austin, TX 78712, United States</aff>
<aff id="A6">
<label>6</label>Department of Pharmacology and Toxicology, Virginia Commonwealth University, Molecular Medicine Research Building 6034, Box 980613, Richmond, VA 23298, United States</aff>
<aff id="A7">
<label>7</label>Department of Psychiatry, Washington University School of Medicine, 660 S. Euclid, CB 8134, Saint Louis, MO 63110, United States</aff>
<author-notes>
<corresp id="FN1">Correspondence concerning this manuscript should be addressed to: Jessica E. Salvatore and Arpana Agrawal. JES: Box 842018, 806 West Franklin Street, Richmond, VA 23284-2018, USA. Phone: +1 (804) 828-8132; fax: +1 (804) 828-2237. <email>jesalvatore@vcu.edu</email>. AA: Department of Psychiatry, Washington University School of Medicine, 660 S. Euclid, CB 8134, Saint Louis, MO 63110, USA. Phone: +1 (314) 286-1778; fax: +1 (314) 286-2213. <email>arpana@wustl.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>6</day>
<month>12</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>09</day>
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>3</month>
<year>2020</year>
</pub-date>
<volume>24</volume>
<issue>2</issue>
<fpage>275</fpage>
<lpage>289</lpage>
<!--elocation-id from pubmed: 10.1111/adb.12591-->
<abstract>
<p id="P1">Alcohol use disorder (AUD) is a heritable complex behavior. Due to the highly polygenic nature of AUD, identifying genetic variants that comprise this heritable variation has proved to be challenging. With the exception of functional variants in alcohol metabolizing genes (e.g., <italic>ADH1B</italic> and <italic>ALDH2</italic>), few other candidate loci have been confidently linked to AUD. Genome-wide association studies (GWAS) of AUD and other alcohol-related phenotypes have either produced few hits with genome-wide significance or have failed to replicate on further study. These issues reinforce the complex nature of the genetic underpinnings for AUD and suggest that both GWAS studies with larger samples and additional analysis approaches that better harness the nominally significant loci in existing GWAS are needed. Here, we review approaches of interest in the post-GWAS era, including <italic>in silico</italic> functional analyses; functional partitioning of SNP heritability; aggregation of signal into genes and gene networks; and validation of identified loci, genes, and gene networks in postmortem brain tissue and across species. These integrative approaches hold promise to illuminate our understanding of the biological basis of AUD; however, we recognize that the main challenge continues to be the extremely polygenic nature of AUD, which necessitates large samples to identify multiple loci associated with AUD liability.</p>
</abstract>
<kwd-group>
<kwd>alcohol use disorder</kwd>
<kwd>cross-species validation</kwd>
<kwd>functional genomics</kwd>
<kwd>translational genomics</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>